CALLABLE MULTI DEFENDER VONTI - NOVO-NORDISK B/ROCHE GS/BAYER Share Price

Certificat

RMBTIV

CH1293287301

Market Closed - Swiss Exchange 16:20:00 15/05/2024 BST
85.7 CHF +0.59% Intraday chart for CALLABLE MULTI DEFENDER VONTI - NOVO-NORDISK B/ROCHE GS/BAYER

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
15/05/24 85.7 +0.59%

Delayed Quote Swiss Exchange

Last update May 15, 2024 at 04:20 pm

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMBTIV
ISINCH1293287301
Date issued 22/09/2023
Strike 249.4 CHF
Maturity 22/09/2025 (495 Days)
Parity 0.25 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 99.7 CHF
Lowest since issue 76.5 CHF

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
224.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.39%
Consensus
  1. Stock Market
  2. Certificates
  3. RMBTIV Certificat